Melanotan 1 (MT1)
Melanotan 1 (MT1)

£19.99

Add to basket This product has multiple variants. The options may be chosen on the product page

Melanotan 1 (MT1)

£19.99

  • UK Stock
  • Secure Payments
  • Discreet UK Delivery

Melanotan 1 (MT1), also known as afamelanotide, is a synthetic 13-amino-acid analogue of α-melanocyte-stimulating hormone, supplied as a lyophilised material for melanocortin-receptor and pigmentation-signalling research.

COMPLETE YOUR KIT

Bacteriostatic Water - 3ml
Bacteriostatic Water - 3ml

In stock

£3.99
GHK-Cu - 50mg
GHK-Cu - 50mg

In stock

£19.99
1 Vial
£19.99
1 Vial
£17.99 Save 10%
3 Vials
£16.99 Save 15%
5 Vials
£15.99 Save 20%

For in vitro laboratory research only.
Not for human or veterinary use. Not for diagnosis, treatment, cure, or prevention of any disease. No dosage, administration, or injection guidance is provided.

Melanotan 1 (MT1), also known as afamelanotide, is a synthetic 13-amino-acid analogue of alpha-melanocyte-stimulating hormone (α-MSH). It is supplied as a lyophilised research material for controlled studies of melanocortin-receptor activity and pigmentation signalling.

Research material only

This product is not supplied as the licensed afamelanotide implant or as any authorised medicine, treatment, cosmetic, supplement or consumer product. It is not for human or veterinary use, consumption or administration, and is not intended to diagnose, treat, cure or prevent any disease.

Compound overview

CompoundMelanotan 1 (MT1)
Alternative nameAfamelanotide
Research classSynthetic α-MSH analogue / MC1R agonist
Reference structureAc-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2
Reference molecular massApproximately 1646.8 Da
FormLyophilised material

Research context

Afamelanotide is commonly described as [Nle4, D-Phe7]-α-MSH, reflecting two substitutions relative to endogenous α-MSH. Published research has examined its binding and signalling at the melanocortin-1 receptor (MC1R), downstream cyclic-AMP responses and melanogenesis in experimental pigmentation models.

Afamelanotide is also the active substance in a separately manufactured and regulated medicinal implant authorised for a specific indication. That authorised implant is not equivalent to this research vial. The cited literature does not establish the identity, purity, performance or suitability of the material supplied on this page.

Batch documentation

Independent analytical documentation is published where available for specific batches and variations. A result indicator appears only when a published record is available. Match the product, stated mass and batch identifier to the corresponding report before relying on any result.

View available Melanotan 1 lab results →

Supply and laboratory handling

  • Supplied in the vial size selected above.
  • Keep the sealed lyophilised vial dry and protected from direct light.
  • A cool, dry place, refrigerator or freezer may be used according to the intended storage duration and your laboratory’s validated procedure.
  • Use clean laboratory technique and equipment appropriate to the intended analytical method.
  • Follow the lot-specific documentation and your laboratory’s validated handling and storage procedures.
  • Avoid repeated temperature cycling and unnecessary exposure to moisture.

Where a batch document or supplier specification gives different instructions, the lot-specific document takes precedence.

Frequently asked questions

What is Melanotan 1?

Melanotan 1, also known as afamelanotide, is a synthetic 13-amino-acid analogue of α-MSH studied in melanocortin-receptor and pigmentation-signalling research.

Is this the authorised afamelanotide medicine?

No. This product is a laboratory research material and is not the licensed afamelanotide implant or any authorised medicine. It is not for human or veterinary use, consumption or administration.

Which vial sizes are available?

Current vial sizes, stock, pre-order status, pricing and any batch-documentation indicators are shown in the variation selector above.

Does every vial size have a published laboratory result?

No. Results are available only for the selected batches and variations marked with a result indicator. Always check that the product, stated mass and batch identifier match the report.

How should the material be stored?

Keep the sealed lyophilised material dry and protected from light. A cool, dry place, refrigerator or freezer may be used according to the intended storage duration and your laboratory’s validated procedure. Avoid repeated temperature cycling and moisture exposure. No universal shelf-life is stated unless it is supported by batch documentation.

Information reviewed: 29 August 2026.

Size

10mg

Batch-specific analytical documentation

Independent analytical results are published for selected Havoc Labs products, vial sizes and batches. The result attached to one variation must not be treated as evidence for a different size or batch.

  • Result available: a published report is available for the marked variation.
  • Test pending: a sample has been submitted, but no completed result is being claimed.
  • No indicator: no product-specific result is currently displayed for that variation.

Check the identifiers

Always match the compound, vial size and batch reference on the product to the corresponding laboratory record. Where the laboratory provides an independent verification facility, use it to confirm the report.

Browse published lab results →

Storage and stability

Storage requirements can vary by compound, physical form, intended storage duration and batch. Follow the lot-specific documentation and your laboratory’s validated procedure wherever these are available.

Form Suggested storage Important note
Sealed lyophilised material Keep in a cool, dry place, refrigerated at 2–8°C or frozen, as appropriate for the compound and intended storage period. Keep sealed, dry and protected from direct light. Follow compound- and batch-specific documentation and avoid repeated temperature cycling.
Reconstituted solution Refrigerate at 2–8°C unless the applicable laboratory protocol specifies otherwise. Stability depends on the preparation conditions, solvent, concentration, container and handling. No universal storage period is claimed.

No universal shelf-life is claimed

Do not assume a fixed expiry or prepared-solution storage period unless it is supported by relevant stability data or batch documentation. Where a lot-specific document gives different instructions, that document takes precedence.

Published research

The sources below provide compound-level context for Melanotan 1 (afamelanotide), including its reference structure, melanocortin-1 receptor signalling, experimental pigmentation research and the regulatory distinction between afamelanotide as a substance and the separately manufactured authorised medicinal implant.

  1. PubChem. Afamelanotide — Compound Summary, CID 16197727. Reference identifiers, structure, sequence, formula and computed molecular mass. View on PubChem ↗
  2. Chluba-de Tapia J et al. Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene. Journal of Cell Science, 1996. Cell-model research including receptor binding with [Nle4, D-Phe7]-α-MSH. View on PubMed ↗
  3. Barnetson RSC et al. Effect of MELANOTAN, [Nle4, D-Phe7]-alpha-MSH, on melanin synthesis in humans with MC1R variant alleles. Peptides, 2006. Controlled clinical research on melanin-density measurements and MC1R variants. View on PubMed ↗
  4. Minder EI et al. Pharmacokinetics and pharmacodynamics of afamelanotide and its clinical use in treating dermatologic disorders. Clinical Pharmacokinetics, 2017. Review of afamelanotide research and regulated clinical formulations. View on PubMed ↗
  5. European Medicines Agency. Scenesse (afamelanotide) regulatory overview. Authoritative information about the separately manufactured authorised medicinal implant. View at EMA ↗

Literature is not batch evidence

The authorised afamelanotide implant described by the EMA is not equivalent to the research vial sold on this page. Published literature does not establish this material’s identity, purity, performance or suitability. Confirm the product, stated mass and batch identifier against the applicable analytical documentation.